Trivandrum

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia1 trial
• Gastric and oesophageal cancer1 trial
• IgA nephropathy1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 43 trials
• Phase 32 trials

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals5 trials

Running trials

• Active, not recruiting

  A Study of Zigakibart in Adults With IgA Nephropathy

  NCT05852938· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation

  NCT06427811· Phase 4· Novartis Pharmaceuticals· Source

• Completed

  Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

  NCT05110196· Phase 4· Novartis Pharmaceuticals· Source

• Completed

  Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine Treatment

  NCT05631795· Phase 4· Novartis Pharmaceuticals· Source

• Completed

  LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

  NCT00680901· Phase 3· Novartis Pharmaceuticals· Source